TrialAdvances in therapy2024

A Phase 3, Open-Label, Single-Arm Trial of the Efficacy and Safety of Triptorelin 6-Month Formulation in Chinese Children with Central Precocious Puberty.

Xiao Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.